News Features ‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings Michael O'Riordan September 17, 2025
News Conference News ESC 2025 Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support Todd Neale August 30, 2025
News Opinion Editor's Corner ESC 2025 What’s Going to Be Hot at ESC Congress 2025? Michael O'Riordan August 25, 2025
News Daily News Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data L.A. McKeown July 24, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Daily News Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study Todd Neale May 09, 2025
News Conference News SCAI 2025 When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer L.A. McKeown May 09, 2025
News Conference News HRS 2025 BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs Todd Neale May 02, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Daily News Food Insecurity in Adulthood Signals Greater Risk of Later CVD Todd Neale March 12, 2025
News Daily News Just One in Five Grand Rounds Lectures Given by Women Michael O'Riordan January 07, 2025
News Conference News AHA 2024 Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F Michael O'Riordan November 16, 2024
News Features GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix? Todd Neale November 13, 2024